Photo from wikipedia
The diagnostic efficacy of contrast‐enhanced magnetic resonance imaging (CEMRI) in diagnosing residual or recurrent hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) is currently not completely clear. Click to show full abstract
The diagnostic efficacy of contrast‐enhanced magnetic resonance imaging (CEMRI) in diagnosing residual or recurrent hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) is currently not completely clear.
Keywords:
hepatocellular carcinoma;
recurrent hepatocellular;
diagnostic efficacy;
residual recurrent;
contrast enhanced;
efficacy contrast
Journal Title: Journal of Magnetic Resonance Imaging
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Magnetic Resonance Imaging
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!